Pyxis Oncology
PYXS • NASDAQ • Stock Fundamentals
Pyxis Oncology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Thomas Civik, with a market cap of $103.3M.
Market Cap$103.3M
Employees51.0
CEOThomas Civik
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Pyxis Oncology FAQ
Common questions about Pyxis Oncology
Pyxis Oncology (PYXS) has a market capitalization of $103.3M and trades on NASDAQ.
Pyxis Oncology has approximately 51 employees.